-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Evommune with Strong Buy Rating, Announces Price Target of $40

Benzinga·01/08/2026 13:03:24
語音播報
Raymond James analyst Martin Auster initiates coverage on Evommune (NYSE:EVMN) with a Strong Buy rating and announces Price Target of $40.